WHO’s stay on HCQ trials was knee-jerk reaction: CSIR chief

Credit: IndiaTimes- Published on June 5, 2020
A day after the World Health Organisation (WHO) endorsed resuming trials of anti-malarial drug hydroxychloroquine (HCQ) for treatment of Covid-19 patients, chief of Council for Scientific and Industrial Research (CSIR) Shekhar C Mande on Thursday welcomed the move saying “the suspension of the trial was based on a study which...
Advertisement

Video credit: HT Digital Content
Published on June 4, 2020 -  01:41
'WHO should've researched independently’: CSIR welcomes HCQ trial resumption
Council of Scientific and Industrial Research (CSIR) welcomed WHO’s move to resume hydroxychloroquine trials. WHO on Thursday said HCQ will return to solidarity trial for potential treatment for Covid-19. CSIR DG DR Shekhar Mande said WHO should have independently researched before halting HCQ trials.

You are here

Related videos from verified sources

‘Not ayurvedic’: CSIR on plant-based drug ACQH to be tested for Covid treatment 01:59
Credit: HT Digital Content - Published on June 6, 2020 


Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct 03:14
Credit: HT Digital Content - Published on May 30, 2020 


You might like